Identifying high-risk comorbidities of short and long-term opioid prescription use
By
Mariela V Jennings,
Hyunjoon Lee,
Daniel B Rocha,
Sevim B Bianchi,
Brandon J Coombes,
Richard C Crist,
Annika Faucon,
Yirui Hu,
Rachel L Kember,
Travis T Mallard,
Maria Niarchou,
Melissa N Poulsen,
Peter Straub,
Richard D Urman,
Colin G Walsh,
PsycheMERGE Substance Use Disorder Workgroup,
Lea K Davis,
Jordan W Smoller,
Vanessa Toiani,
Sandra Sanchez-Roige
Posted 24 Nov 2021
medRxiv DOI: 10.1101/2021.11.23.21266717
Background Electronic health records (EHR) are useful tools for understanding complex medical phenotypes, but they have been underutilized for opioid use disorders (OUD). Patterns of prescription opioid use might provide an objective measure of OUD risk. Methods We extracted data for over 2.6 million patients across three health registries (Vanderbilt University Medical Center, Mass General Brigham, Geisinger) between 2005 and 2018. We defined three groups based on levels of opioid exposure: No Prescription, Minimal Exposure (2 prescriptions within 90 days at least once, but never 3 prescriptions <90 days apart), and Chronic Exposure ([≥]10 opioid prescriptions in a year), and compared them to the full registries and to patients with OUD diagnostic codes. We extracted demographic and clinical characteristics known to co-occur with OUD, including psychiatric and substance use disorders, pain-related diagnoses, HIV, and hepatitis C. Results The prevalence of substance (alcohol, tobacco, cannabis) use disorders was higher in patients with OUD and Chronic Exposure than those with No Prescription or Minimal Exposure. Patients in the OUD and Chronic Exposure groups had more psychiatric (anxiety, depression, schizophrenia, bipolar disorder) and medical comorbidities (pain, hepatitis C, HIV) than those in the Minimal Exposure group. Notably, patients in the Minimal Exposure group had different comorbidity profiles (higher rates of substance use and psychiatric disorders, more pain conditions) than those in the Unscreened or No Prescription groups, highlighting the value of including opioid exposure in studies of OUD. Conclusions Long-term opioid prescription use may serve as an additional tool to characterize OUD risk.
Download data
- Downloaded 264 times
- Download rankings, all-time:
- Site-wide: 170,703
- In addiction medicine: 109
- Year to date:
- Site-wide: 106,002
- Since beginning of last month:
- Site-wide: 85,614
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!